Literature DB >> 19412814

Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS.

Anna Wuolikainen1, Mattias Hedenström, Thomas Moritz, Stefan L Marklund, Henrik Antti, Peter M Andersen.   

Abstract

There is a need for biomarkers for early diagnosis, development and evaluation of treatment efficacy in amyotrophic lateral sclerosis (ALS). We aimed to investigate if pre-analytical factors induce artefacts in metabolomic data of cerebrospinal fluid (CSF) from patients with ALS. CSF from 16 patients was studied using a statistical experimental design protocol with the following parameters: storage temperature (-80 degrees C/ - 20 degrees C), type of collection tube (polypropylene/polystyrene), and time delay from collecting to freezing (0, 10, 30, 90, 150 min). Gas chromatography-mass spectrometry was used to analyse CSF from 12 of the patients while CSF from one patient was analysed with nuclear magnetic resonance spectroscopy. The extent of CO(2) evaporization from CSF collected in tubes of different sizes at different temperatures and with/without lid were studied in three addtional patients. We found that alterations in storage temperature affect the metabolite composition of CSF more than any other studied pre-analytical parameter. CO(2) evaporization may induce artefacts in the metabolome by increasing the pH. In conclusion, minimization of evaluated artefacts can be obtained by collecting the CSF directly into tubes with tightly sealed lids in N(2)(l) and after freezing transfer of the tubes to -80 degrees C to minimize evaporation of CO(2).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19412814     DOI: 10.1080/17482960902871009

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  14 in total

1.  Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis.

Authors:  Marek J Noga; Adrie Dane; Shanna Shi; Amos Attali; Hans van Aken; Ernst Suidgeest; Tinka Tuinstra; Bas Muilwijk; Leon Coulier; Theo Luider; Theo H Reijmers; Rob J Vreeken; Thomas Hankemeier
Journal:  Metabolomics       Date:  2011-04-16       Impact factor: 4.290

Review 2.  MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis.

Authors:  Frank Cloutier; Alier Marrero; Colleen O'Connell; Pier Morin
Journal:  J Mol Neurosci       Date:  2014-11-30       Impact factor: 3.444

Review 3.  LC-MS-based metabolomics.

Authors:  Bin Zhou; Jun Feng Xiao; Leepika Tuli; Habtom W Ressom
Journal:  Mol Biosyst       Date:  2011-11-01

Review 4.  Biomarkers in frontotemporal lobar degenerations--progress and challenges.

Authors:  William T Hu; John Q Trojanowski; Leslie M Shaw
Journal:  Prog Neurobiol       Date:  2011-04-30       Impact factor: 11.685

5.  1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis.

Authors:  Hélène Blasco; Philippe Corcia; Caroline Moreau; Ségolène Veau; Clémentine Fournier; Patrick Vourc'h; Patrick Emond; Paul Gordon; Pierre-François Pradat; Julien Praline; David Devos; Lydie Nadal-Desbarats; Christian R Andres
Journal:  PLoS One       Date:  2010-10-08       Impact factor: 3.240

6.  Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS.

Authors:  Anna Wuolikainen; Thomas Moritz; Stefan L Marklund; Henrik Antti; Peter Munch Andersen
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

7.  Validated and predictive processing of gas chromatography-mass spectrometry based metabolomics data for large scale screening studies, diagnostics and metabolite pattern verification.

Authors:  Elin Thysell; Elin Chorell; Michael B Svensson; Pär Jonsson; Henrik Antti
Journal:  Metabolites       Date:  2012-10-31

8.  1H NMR Analysis of Cerebrospinal Fluid from Alzheimer's Disease Patients: An Example of a Possible Misinterpretation Due to Non-Adjustment of pH.

Authors:  Thomas Cruz; Stéphane Balayssac; Véronique Gilard; Robert Martino; Christian Vincent; Jérémie Pariente; Myriam Malet-Martino
Journal:  Metabolites       Date:  2014-02-19

Review 9.  Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Robert Bowser; Lucie Bruijn; Luc Dupuis; Albert Ludolph; Michael McGrath; Giovanni Manfredi; Nicholas Maragakis; Robert G Miller; Seth L Pullman; Seward B Rutkove; Pamela J Shaw; Jeremy Shefner; Kenneth H Fischbeck
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05       Impact factor: 4.092

Review 10.  Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michael Benatar
Journal:  Muscle Nerve       Date:  2014-11-24       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.